Impact of thyroid dysfunction on serum cystatin C.

BACKGROUND Serum cystatin C (CysC) is a novel marker for kidney function that has been claimed to be superior to serum creatinine. Thyroid dysfunction may alter creatinine, which has been found to be increased in hypothyroidism and decreased in hyperthyroidism. This study was performed to evaluate whether changes in CysC and creatinine are parallel during the treatment of hypo- and hyperthyroidism, respectively. METHODS Prospective case series of 22 consecutively referred patients with thyroid dysfunction. Creatinine and CysC were determined at the time of diagnosis of hypo- and hyperthyroidism, and when free thyroxine (fT4) returned into the normal range. Hypothyroid patients were treated with levothyroxine. Hyperthyroid patients were treated with antithyroid drugs, surgery, or radioiodine. RESULTS Nine patients with hypothyroidism and 13 patients with hyperthyroidism were included. In patients with hypothyroidism mean fT4 (+/-SD) was 4.9 +/- 2.5 pmol/L (reference, 12 to 22) at diagnosis and increased to 16.6 +/- 3.6 pmol/L when patients were treated with levothyroxine. Creatinine decreased from 86 +/- 13 micromol/L (reference, 70 to 105) in the hypothyroid state to 76 +/- 16 micromol/L when fT4 normalized (P = 0.062), whereas CysC increased from 0.84 +/- 0.17 mg/L (reference, 0.63 to 1.33) to 1.1 +/- 0.28 mg/L (P < 0.001). In patients with hyperthyroidism, mean fT4 was 54.6 +/- 22.7 pmol/L (reference, 12 to 22) at diagnosis and decreased to 15.8 +/- 3.6 pmol/L following treatment with antithyroid drugs, thyroid surgery, or radioiodine. Creatinine increased from 67 +/- 15 micromol/L at diagnosis of hyperthyroidism to 75 +/- 9 micromol/L when fT4 normalized (P = 0.004), whereas CysC declined from 1.32 +/- 0.17 mg/L to 0.95 +/- 0.19 mg/L (P < 0.001). CONCLUSION Thyroid dysfunction has a major impact on CysC levels. Therefore, thyroid function has to be considered when CysC is used as a marker of kidney function. In contrast to creatinine concentrations, CysC levels are lower in the hypothyroid and higher in the hyperthyroid state as compared with the euthyroid state.

[1]  C. Price,et al.  Cystatin C: an improved estimator of glomerular filtration rate? , 2002, Clinical chemistry.

[2]  G. Siest,et al.  Determination of Serum Cystatin C: Biological Variation and Reference Values , 2001, Clinical chemistry and laboratory medicine.

[3]  C. Wagner,et al.  Cystatin C, an early indicator for incipient renal disease in rheumatoid arthritis. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[4]  T. Sauerbruch,et al.  Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. , 2000, Clinical chemistry.

[5]  P. Nilsson-ehle,et al.  Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. , 1999, Scandinavian journal of clinical and laboratory investigation.

[6]  R. Zinck,et al.  Cystatin C serum concentrations underestimate glomerular filtration rate in renal transplant recipients. , 1999, Clinical chemistry.

[7]  E. Erlandsen,et al.  Serum Cystatin C as an Endogenous Marker of the Renal Function – a Review , 1999, Clinical chemistry and laboratory medicine.

[8]  J. Hennessey,et al.  Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. , 1999, Archives of internal medicine.

[9]  B. Keevil,et al.  Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. , 1998, Clinical chemistry.

[10]  K. Hruska,et al.  Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. , 1998, Clinical chemistry.

[11]  J. Kos,et al.  Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  P. D. De Deyn,et al.  Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction. , 1997, Metabolism: clinical and experimental.

[13]  R. Lafayette,et al.  Increased serum creatinine in the absence of renal failure in profound hypothyroidism. , 1994, The American journal of medicine.

[14]  I. Olafsson,et al.  Structure and expression of the human cystatin C gene. , 1990, The Biochemical journal.

[15]  J. Pearce,et al.  RENAL FUNCTION AND ELECTROLYTE LEVELS IN HYPERTHYROIDISM: URINARY PROTEIN EXCRETION AND THE PLASMA CONCENTRATIONS OF UREA, CREATININE, URIC ACID, HYDROGEN ION AND ELECTROLYTES , 1989, Clinical endocrinology.

[16]  H. Thysell,et al.  The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. , 1985, Scandinavian journal of clinical and laboratory investigation.

[17]  A. Barrett,et al.  The place of human γ-trace (cystatin C) amongst the cysteine proteinase inhibitors , 1984 .